Siming Ai
Impact in
- Ophthalmology top 5%
- Ocular Oncology and Treatments
- Glaucoma and retinal disorders
-
- Ophthalmology and Eye Disorders
Papers in
-
- Ocular Oncology and Treatments 6
-
- Hedgehog Signaling Pathway Studies 2
- Co-authors
- Yuxiang Mao (13 shared papers)Huijing Ye (6 shared papers)Rong Lu (8 shared papers)Rongxin Chen (5 shared papers)Huasheng Yang (5 shared papers)Dan Liang (2 shared papers)Xuanwei Liang (3 shared papers)Wenfang Ma (3 shared papers)
- Journals
- Journal of Pain Research (1 paper)Tissue and Cell (1 paper)International Immunopharmacology (1 paper)European Journal of Medicinal Chemistry (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Siming Ai
25 papers receiving 256 citations
Peers
Comparison fields: 5 of 51
- Ophthalmology 64
- Pathology and Forensic Medicine 38
- Cancer Research 23
- Rheumatology 23
- Oncology 37
Countries citing papers authored by Siming Ai
This map shows the geographic impact of Siming Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siming Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siming Ai more than expected).
Fields of papers citing papers by Siming Ai
This network shows the impact of papers produced by Siming Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siming Ai. The network helps show where Siming Ai may publish in the future.
Co-authors
The 25 scholars most cited alongside Siming Ai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 25 | |
| 2 | 2020 | 25 | |
| 3 | 2015 | 24 | |
| 4 | FGFR2 molecular analysis and related clinical findings in one Chinese family with Crouzon syndrome. | 2012 | 16 |
| 5 | 2017 | 15 | |
| 6 | Ala344Pro mutation in the FGFR2 gene and related clinical findings in one Chinese family with Crouzon syndrome. | 2012 | 13 |
| 7 | 2017 | 13 | |
| 8 | 2020 | 13 | |
| 9 | 2019 | 13 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 12 | |
| 12 | 2016 | 12 | |
| 13 | 2024 | 10 | |
| 14 | [Diagnosis and surgical management of 209 cases of orbital cavernous hemangioma]. | 2006 | 7 |
| 15 | 2024 | 6 | |
| 16 | 2015 | 6 | |
| 17 | 2017 | 6 | |
| 18 | Clinical analysis of 106 cases with elevated intraocular pressure in thyroid-associated ophthalmopathy. | 2004 | 5 |
| 19 | 2025 | 5 | |
| 20 | 2024 | 4 |
About Siming Ai
Siming Ai is a scholar working on Ophthalmology, Molecular Biology, Genetics, Pathology and Forensic Medicine and Oncology, having authored 28 papers that have together received 257 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (6 papers), Craniofacial Disorders and Treatments (5 papers), Ophthalmology and Eye Disorders (4 papers), Cancer-related Molecular Pathways (3 papers), Cleft Lip and Palate Research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Sympathectomy and Hyperhidrosis Treatments (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). The work is most often cited by research in Ophthalmology (64 citations), Pathology and Forensic Medicine (38 citations), Cancer Research (23 citations), Rheumatology (23 citations) and Oncology (37 citations). Siming Ai has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yuxiang Mao, Huijing Ye, Rong Lu, Rongxin Chen, Huasheng Yang, Dan Liang, Xuanwei Liang, Huasheng Yang, Wenfang Ma and Jianhua Yan. Their work appears in journals such as Journal of Pain Research, Tissue and Cell, International Immunopharmacology, European Journal of Medicinal Chemistry and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.